PREVENT Cancer Preclinical Drug Development Program (PREVENT)

Image of a scientist preparing genetic samples.

PREVENT supports development of the best ideas in cancer prevention intervention and biomarkers using NCI contract resources instead of direct funding. The program is a peer-reviewed pipeline that focuses on research needs that are not adequately addressed by the private sector.

Read more About PREVENT.

 

Application Instructions

Submission deadlines occur twice per year on the first Monday in February and September.

NEXT Deadline: February 5, 2018

Instructions for Applying
The application template was updated on 09/12/2017.

Supported Projects

69 Projects from 11 application cycles include: 

  • 43 small molecules
  • 18 vaccines
  • 8 biomarkers

More on each project and the supported prevention approaches

Available Resources

  • Efficacy and Intermediate Endpoint Biomarker Work
  • Toxicology and Pharmacology Testing
  • Prime Contractors 2015-2018

View Available Resources

Program Administration

  • Governance Structure
  • Intellectual Property Considerations
  • Data Access

Learn more about Program Administration